Age-specific evaluation of HPV DNA testing vs. cytology screening

Nov 10, 2009

Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online November 9 in the Journal of the National Cancer Institute. Cytology triage in HPV-positive women can improve specificity.

HPV DNA testing has shown higher sensitivity than conventional cytology screening for detecting cervical lesions, but it is uncertain whether the higher sensitivity is dependent on the age of the woman being screened.

Maarit Leinonen, M.D., of the Mass Screening Registry, Finnish Cancer Registry in Helsinki, and colleagues compared the age-specific performance of primary DNA screening with that of conventional cytology screening. Finnish women aged 25-65 years were sent randomized invitations for HPV DNA testing with cytology triage or conventional screening.

Overall, primary HPV DNA screening with cytology triage was more sensitive than conventional screening for detecting cervical lesions. Among women younger than 35 years, those who got HPV DNA screening were referred for colposcopy more often than those who got conventional screening. Among women aged 35 years or older, HPV DNA testing with cytology triage was more sensitive and more specific than conventional screening, had a higher precision rate, and was associated with fewer colposcopy referrals and follow-up tests.

"In countries like Finland that have a well-organized cervical screening program and low incidence of , new interventions are expected to provide only small increases in a screening program's efficacy," the authors write. "Nevertheless, our results support the use of HPV with cytology triage in primary cervical screening."

In an accompanying editorial, Eduardo L. Franco, MPH, DrPH, said that "this finding underscores the importance of cytology as a triage test in preserving the specificity of the HPV DNA screening approach."

He also suggests that use of an automated and objective molecular test, such as the HPV assay, as an initial screening step increases the prevalence of abnormal smears destined for cytology reading, thus avoiding the monotony of reading smears in primary screening. In the post-vaccination era, when the prevalence of cervical abnormalities is expected to decrease, this enrichment step may preserve the positive predictive value of the HPV-followed-by Pap approach.

Source: (news : web)

Explore further: Six percent of colorectal cancer found to be interval tumors

add to favorites email to friend print save as pdf

Related Stories

Study: HPV test beats Pap in detecting cervical cancer

Oct 18, 2007

A new study led by McGill University researchers shows that the human papillomavirus (HPV) screening test is far more accurate than the traditional Pap test in detecting cervical cancer. The first round of the Canadian Cervical ...

Cervical cancer screening: Too many are left unprotected

Sep 19, 2007

The decline in cervical cancer is a success story of cancer research. Although there are reasons to be optimistic about even further decreases in cervical cancer incidence, there still remain some women who are not screened. ...

Recommended for you

Physicians target the genes of lung, colon cancers

9 hours ago

(Medical Xpress)—University of Florida physicians and researchers are collaborating to map the genes of different types of cancer, and then deliver medication to attack cancer at its source.

User comments : 0

More news stories

Down's chromosome cause genome-wide disruption

The extra copy of Chromosome 21 that causes Down's syndrome throws a spanner into the workings of all the other chromosomes as well, said a study published Wednesday that surprised its authors.

Ebola virus in Africa outbreak is a new strain

The Ebola virus that has killed scores of people in Guinea this year is a new strain—evidence that the disease did not spread there from outbreaks in some other African nations, scientists report.

Freight train industry to miss safety deadline

The U.S. freight railroad industry says only one-fifth of its track will be equipped with mandatory safety technology to prevent most collisions and derailments by the deadline set by Congress.